Absence of CD59 exacerbates systemic autoimmunity in MRL/lpr mice

Journal of Immunology

Volumn 189, Issue 11, 2012, Pages 5434-5441

  Miwa, Takashi ^a   Zhou, Lin ^a   Maldonado, Michael A ^b,d   Madaio, Michael P ^c   Eisenberg, Robert A ^b   Song, Wen Chao ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD59 ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; BACKCROSSING; BONE MARROW CELL; CONTROLLED STUDY; GENE DELETION; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEINURIA; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANEMIA, HEMOLYTIC; ANIMALS; ANTIBODIES; ANTIGENS, CD59; AUTOANTIBODIES; AUTOIMMUNITY; COMPLEMENT C3; COMPLEMENT C5; DERMATITIS; FEMALE; GENE EXPRESSION; HEMOGLOBINURIA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICE, INBRED MRL LPR; MICE, KNOCKOUT; PROTEINURIA; SEX FACTORS; SKIN; T-LYMPHOCYTES;

EID: 84869753991     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201621     Document Type: Article

References (46)

1. Mills, J. A. 1994. Systemic lupus erythematosus. N. Engl. J. Med. 330: 1871-1879.
2. Kotzin, B. L. 1996. Systemic lupus erythematosus. Cell 85: 303-306. (Pubitemid 26160701)
3. Manderson, A. P., M. Botto, and M. J.Walport. 2004. The role of complement in the development of systemic lupus erythematosus. Annu. Rev. Immunol. 22: 431-456. (Pubitemid 38680429)
4. Einav, S., O. O. Pozdnyakova, M. Ma, and M. C. Carroll. 2002. Complement C4 is protective for lupus disease independent of C3. J. Immunol. 168: 1036-1041. (Pubitemid 34094466)
5. Mitchell, D. A., M. C. Pickering, J. Warren, L. Fossati-Jimack, J. Cortes-Hernandez, H. T. Cook, M. Botto, and M. J. Walport. 2002. C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J. Immunol. 168: 2538-2543. (Pubitemid 34171862)
6. Chen, Z., S. B. Koralov, and G. Kelsoe. 2000. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J. Exp. Med. 192: 1339-1352.
7. Cook, H. T., and M. Botto. 2006. Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 2: 330-337. (Pubitemid 43842262)
8. Watanabe, H., G. Garnier, A. Circolo, R. A. Wetsel, P. Ruiz, V. M. Holers, S. A. Boackle, H. R. Colten, and G. S. Gilkeson. 2000. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J. Immunol. 164: 786-794. (Pubitemid 30043702)
9. Elliott, M. K., T. Jarmi, P. Ruiz, Y. Xu, V. M. Holers, and G. S. Gilkeson. 2004. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice. Kidney Int. 65: 129-138. (Pubitemid 38037497)
10. Sekine, H., C. M. Reilly, I. D. Molano, G. Garnier, A. Circolo, P. Ruiz, V. M. Holers, S. A. Boackle, and G. S. Gilkeson. 2001. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice. J. Immunol. 166: 6444-6451. (Pubitemid 32440780)
11. Alexander, J. J., and R. J. Quigg. 2007. The simple design of complement factor H: Looks can be deceiving. Mol. Immunol. 44: 123-132. (Pubitemid 44647114)
12. Miwa, T., and W. C. Song. 2001. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases. Int. Immunopharmacol. 1: 445-459. (Pubitemid 32197543)
13. Miwa, T., M. A. Maldonado, L. Zhou, K. Yamada, G. S. Gilkeson, R. A. Eisenberg, and W. C. Song. 2007. Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms. Am. J. Pathol. 170: 1258-1266. (Pubitemid 47339333)
14. Liu, J., T. Miwa, B. Hilliard, Y. Chen, J. D. Lambris, A. D. Wells, and W. C. Song. 2005. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J. Exp. Med. 201: 567-577. (Pubitemid 40289547)
15. + T cell activity in a complement-independent manner. J. Immunol. 175: 7098-7102.
16. Longhi, M. P., A.Williams, M.Wise, B. P. Morgan, and A. Gallimore. 2007. CD59a deficiency exacerbates influenza-induced lung inflammation through complement-dependent and -independent mechanisms. Eur. J. Immunol. 37: 1266-1274. (Pubitemid 46925311)
17. Yamashina, M., E. Ueda, T. Kinoshita, T. Takami, A. Ojima, H. Ono, H. Tanaka, N. Kondo, T. Orii, N. Okada, et al. 1990. Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. N. Engl. J. Med. 323: 1184-1189. (Pubitemid 20347405)
18. Fakhouri, F., V. Frémeaux-Bacchi, L. H. Noël, H. T. Cook, and M. C. Pickering. 2010. C3 glomerulopathy: a new classification. Nat. Rev. Nephrol. 6: 494-499.
19. Kavanagh, D., A. Richards, and J. Atkinson. 2008. Complement regulatory genes and hemolytic uremic syndromes. Annu. Rev. Med. 59: 293-309. (Pubitemid 351287939)
20. Miwa, T., M. A. Maldonado, L. Zhou, X. Sun, H. Y. Luo, D. Cai, V. P. Werth, M. P. Madaio, R. A. Eisenberg, and W. C. Song. 2002. Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice. Am. J. Pathol. 161: 1077-1086. (Pubitemid 34988395)
21. Powell, M. B., K. J. Marchbank, N. K. Rushmere, C. W. van den Berg, and B. P. Morgan. 1997. Molecular cloning, chromosomal localization, expression, and functional characterization of the mouse analogue of human CD59. J. Immunol. 158: 1692-1702. (Pubitemid 127469523)
22. Qin, X., T. Miwa, H. Aktas, M. Gao, C. Lee, Y. M. Qian, C. C. Morton, A. Shahsafaei, W. C. Song, and J. A. Halperin. 2001. Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59b. Mamm. Genome 12: 582-589. (Pubitemid 32675523)
23. Qian, Y. M., X. Qin, T. Miwa, X. Sun, J. A. Halperin, and W. C. Song. 2000. Identification and functional characterization of a new gene encoding the mouse terminal complement inhibitor CD59. J. Immunol. 165: 2528-2534. (Pubitemid 30660698)
24. Miwa, T., L. Zhou, B. Hilliard, H. Molina, and W. C. Song. 2002. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. Blood 99: 3707-3716. (Pubitemid 34534542)
25. Molina, H., T. Miwa, L. Zhou, B. Hilliard, D. Mastellos, M. A. Maldonado, J. D. Lambris, and W. C. Song. 2002. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Blood 100: 4544-4549. (Pubitemid 35429696)
26. Chan, O. T., M. P. Madaio, and M. J. Shlomchik. 1999. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. J. Immunol. 163: 3592-3596. (Pubitemid 29450878)
27. Shlomchik, M. J., M. P. Madaio, D. Ni, M. Trounstein, and D. Huszar. 1994. The role of B cells in lpr/lpr-induced autoimmunity. J. Exp. Med. 180: 1295-1306. (Pubitemid 24289603)
28. Lesher, A. M., L. Zhou, Y. Kimura, S. Sato, D. Gullipalli, M. M. Ruseva, M. C. Pickering, A. P. Herbert, P. N. Barlow, H. U. Eberhardt, et al. 2012. Lethal murine C3 glomerulonephritis resembling human dense deposit disease caused by combined fH C-terminal mutation and properdin deficiency. J. Am. Soc. Nephrol. In press.
29. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317.
30. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9: 243-269.
31. Morse, H. C., III, W. F. Davidson, R. A. Yetter, E. D. Murphy, J. B. Roths, and R. L. Coffman. 1982. Abnormalities induced by the mutant gene Ipr: expansion of a unique lymphocyte subset. J. Immunol. 129: 2612-2615.
32. Zhang, Z., V. C. Kyttaris, and G. C. Tsokos. 2009. The role of IL-23/IL-17 axis in lupus nephritis. J. Immunol. 183: 3160-3169.
33. Wang, Y., Q. Hu, J. A. Madri, S. A. Rollins, A. Chodera, and L. A. Matis. 1996. Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc. Natl. Acad. Sci. USA 93: 8563-8568. (Pubitemid 26269599)
34. Lublin, D. M., and J. P. Atkinson. 1989. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7: 35-58. (Pubitemid 19138006)
35. Holt, D. S., M. Botto, A. E. Bygrave, S. M. Hanna, M. J. Walport, and B. P. Morgan. 2001. Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood 98: 442-449.
36. Beurskens, F. J., J. D. Kuenen, F. Hofhuis, A. C. Fluit, D. M. Robins, and H. Van Dijk. 1999. Sex-limited protein: in vitro and in vivo functions. Clin. Exp. Immunol. 116: 395-400. (Pubitemid 29258086)
37. Whitacre, C. C. 2001. Sex differences in autoimmune disease. Nat. Immunol. 2: 777-780.
38. Harris, C. L., S. M. Hanna, M. Mizuno, D. S. Holt, K. J. Marchbank, and B. P. Morgan. 2003. Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison. Immunology 109: 117-126. (Pubitemid 36577982)
39. Huber-Lang, M., J. V. Sarma, F. S. Zetoune, D. Rittirsch, T. A. Neff, S. R. McGuire, J. D. Lambris, R. L. Warner, M. A. Flierl, L. M. Hoesel, et al. 2006. Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12: 682-687. (Pubitemid 43865238)
40. Yamada, K., T. Miwa, J. Liu, M. Nangaku, and W. C. Song. 2004. Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J. Immunol. 172: 3869-3875. (Pubitemid 38337974)
41. Carlucci, F., J. Cortes-Hernandez, L. Fossati-Jimack, A. E. Bygrave, M. J. Walport, T. J. Vyse, H. T. Cook, and M. Botto. 2007. Genetic dissection of spontaneous autoimmunity driven by 129-derived chromosome 1 loci when expressed on C57BL/6 mice. J. Immunol. 178: 2352-2360. (Pubitemid 46233434)
42. Carlucci, F., L. Fossati-Jimack, I. E. Dumitriu, Y. Heidari, M. J. Walport, M. Szajna, P. Baruah, O. A. Garden, H. T. Cook, and M. Botto. 2010. Identification and characterization of a lupus suppressor 129 locus on chromosome 3. J. Immunol. 184: 6256-6265.
43. Kimberley, F. C., B. Sivasankar, and B. Paul Morgan. 2007. Alternative roles for CD59. Mol. Immunol. 44: 73-81. (Pubitemid 44647106)
44. Harder, T., and K. Simons. 1999. Clusters of glycolipid and glycosylphosphatidylinositol-anchored proteins in lymphoid cells: accumulation of actin regulated by local tyrosine phosphorylation. Eur. J. Immunol. 29: 556-562. (Pubitemid 29078516)
45. Deckert, M., J. Kubar, D. Zoccola, G. Bernard-Pomier, P. Angelisova, V. Horejsi, and A. Bernard. 1992. CD59 molecule: a second ligand for CD2 in T cell adhesion. Eur. J. Immunol. 22: 2943-2947.
46. Hahn, W. C., E. Menu, A. L. Bothwell, P. J. Sims, and B. E. Bierer. 1992. Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science 256: 1805-1807.